Graig Suvannavejh – Goldman Sachs

Goldman Sachs

A Goldman Sachs analyst with 7 tracked ratings across 7 distinct tickers has a hold count of 2 and an 83.3% success rate on the captured sample, focusing exclusively on one source.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

6 months ago

2025-11-18 00:00:00+00

Track record

Aggregated

83% success rate

Bullish: 0
Hold: 3
Bearish: 0

Aggregated

Not available

Bullish: 0
Hold: 1
Bearish: 0

Recent ratings

Ticker	Date	Rating	Price target	Source
HALO	2025-11-18	hold	$56.00	Aggregated
HALOHALOZYME THERAPEUTICS INC.	2025-11-18	hold	$56.00	Aggregated
HALOHALOZYME THERAPEUTICS INC.	2024-07-22	hold	$49.00	Aggregated
KODKODIAK SCIENCES INC	2022-11-10	hold	$8.00	Aggregated
RYTMRHYTHM PHARMACEUTICALS INC.	2022-11-10	unknown	$35.00	Aggregated
CYTKCYTOKINETICS INC	2022-05-24	unknown	$57.00	Aggregated
TGTXTG THERAPEUTICS INC	2022-04-19	unknown	$5.00	Aggregated
VALNVALNEVA SE - ADR	2021-06-01	unknown	$34.00	Aggregated
RAINRAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC. CLASS A COMMON STOCK	2021-05-18	unknown	$56.00	Aggregated

Tickers covered(8)

Ticker	Ratings	Last rating	Sources
HALO	1	2025-11-18	Aggregated
HALOHALOZYME THERAPEUTICS INC.	2	2025-11-18	Aggregated
KODKODIAK SCIENCES INC	1	2022-11-10	Aggregated
RYTMRHYTHM PHARMACEUTICALS INC.	1	2022-11-10	Aggregated
CYTKCYTOKINETICS INC	1	2022-05-24	Aggregated
TGTXTG THERAPEUTICS INC	1	2022-04-19	Aggregated
VALNVALNEVA SE - ADR	1	2021-06-01	Aggregated
RAINRAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC. CLASS A COMMON STOCK	1	2021-05-18	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.